相关实验视频

Updated: Aug 11, 2026

Optimized Fibrin Gel Bead Assay for the Study of Angiogenesis
14:14

Optimized Fibrin Gel Bead Assay for the Study of Angiogenesis

Published on: April 29, 2007

31.9K

一种纤维素度的长期安全性分析 (RiaSTAP®/Haemocomplettan®)

Niels Rahe-Meyer1,2, Gabriele Neumann3, Dirk S Schmidt4

  • 1Department for Anaesthesiology and Intensive Care Medicine, Franziskus Hospital Bielefeld, Bielefeld, Germany.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|May 28, 2024
PubMed
概括

纤维素缩剂有效治疗纤维素缺乏症患者的出血. 营销后的数据和研究表明,药物不良反应的风险很低,包括血栓栓塞事件,支持其有利的安全性.

关键词:
药物不良反应 药物不良反应纤维原缩物纤维原缩物在营销后的时间.在安全方面,安全是安全的.

更多相关视频

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial08:14

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Published on: September 29, 2015

12.9K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...